SLG
LMAT icon

Stanley-Laman Group’s LeMaitre Vascular LMAT Stock Holding History

Stanley-Laman Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,740
Closed -$489K – 294
2021
Q4 		$489K Buy
+9,740
New +$504K 0.06% 219

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Stanley-Laman Group's LMAT Position: Q1 2022 in Review

Stanley-Laman Group sold out of LeMaitre Vascular (LMAT) in Q1 2022, closing a stake of 9,740 shares — an estimated $489K sold.

Stanley-Laman Group first reported a position in LMAT in Q4 2021 and held it in 1 quarter. The position peaked at $489K in Q4 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.

  • Stanley-Laman Group reported no remaining LeMaitre Vascular position as of Q1 2022 after selling out during the quarter.
  • Stanley-Laman Group sold 9,740 LeMaitre Vascular shares in Q1 2022, an estimated $489K.
  • Stanley-Laman Group first reported a position in LeMaitre Vascular in Q4 2021 and held it in 1 quarter.
  • Stanley-Laman Group's LeMaitre Vascular position peaked at $489K in Q4 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.

Based on Stanley-Laman Group's 13F filing for Q1 2022, filed 21 Apr 2022.